Wyeth Wants Premarin Petitions Excluded From Duramed Antitrust Suit
Executive Summary
Wyeth-Ayerst's efforts to influence regulatory decisions about conjugated estrogens via citizens' petitions are an early focus of arguments in Duramed's antitrust suit against the company.
You may also be interested in...
Cenestin Sales Force Will Promote Seasonale After Barr/Duramed Merger
Barr's oral contraceptive Seasonale will be promoted by Duramed's Cenestin sales force following a merger between the two generic/brand drug companies.
Cenestin Sales Force Will Promote Seasonale After Barr/Duramed Merger
Barr's oral contraceptive Seasonale will be promoted by Duramed's Cenestin sales force following a merger between the two generic/brand drug companies.
Duramed Cenestin And Pfizer Aricept In Pilot Study For Early Alzheimer's
Duramed is planning clinical studies of its synthetic conjugated estrogen Cenestin in combination with Pfizer/Eisai's Aricept for treatment of early Alzheimer's disease, the company said during a Feb. 28 conference call.